More about

Endometrial Cancer

News
March 31, 2023
1 min read
Save

Top news from SGO: Updates in endometrial, ovarian, cervical cancer and more

Top news from SGO: Updates in endometrial, ovarian, cervical cancer and more

The Healio Editors compiled a list of recent news from the Society of Gynecologic Oncology Annual Meeting held from March 25-28, 2023.

News
March 28, 2023
3 min read
Save

Dostarlimab study ‘will change the lives of our patients’ with endometrial cancer

Dostarlimab study ‘will change the lives of our patients’ with endometrial cancer

Dostarlimab plus carboplatin significantly increased PFS among women with primary advanced or recurrent endometrial cancer, according to study results presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

News
March 28, 2023
3 min read
Save

Study of pembrolizumab regimen in endometrial cancer yields ‘encouraging new finding’

Study of pembrolizumab regimen in endometrial cancer yields ‘encouraging new finding’

The addition of pembrolizumab to chemotherapy significantly extended PFS for women with advanced or recurrent endometrial cancer, according to study results presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

News
February 09, 2023
1 min read
Save

FDA grants regular approval to Jemperli for advanced endometrial cancer

FDA grants regular approval to Jemperli for advanced endometrial cancer

The FDA granted regular approval to dostarlimab-gxly for treatment of certain women with endometrial cancer.

News
February 03, 2023
1 min read
Save

Pembrolizumab regimen extends PFS in advanced, recurrent endometrial carcinoma

Pembrolizumab regimen extends PFS in advanced, recurrent endometrial carcinoma

The addition of pembrolizumab to chemotherapy significantly extended PFS as first-line treatment for advanced or recurrent endometrial carcinoma, according to the agent’s manufacturer.

News
December 12, 2022
2 min read
Save

Tamoxifen treatment for breast cancer may increase endometrial disease, cancer risks

Tamoxifen treatment for breast cancer may increase endometrial disease, cancer risks

Tamoxifen use in the treatment of breast cancer was associated with greater risks for endometrial cancer, hyperplasia and polyps, as well as other uterine cancers among premenopausal women in Korea, according to study data.

News
December 02, 2022
1 min read
Save

Dostarlimab-gxly regimen extends PFS in primary advanced or recurrent endometrial cancer

Dostarlimab-gxly regimen extends PFS in primary advanced or recurrent endometrial cancer

A combination of dostarlimab-gxly and standard-of-care chemotherapy significantly extended PFS compared with placebo and chemotherapy among women with primary advanced or recurrent endometrial cancer, topline data showed.

News
November 17, 2022
2 min read
Save

Having more live births lowers endometrial cancer risk

Having more live births lowers endometrial cancer risk

A greater number of live births causally reduced the risk for endometrial cancer, according to study results published in BMC Medicine.

News
September 09, 2022
3 min read
Save

Novel bispecific T-cell receptor therapy shows early promise in advanced solid tumors

Novel bispecific T-cell receptor therapy shows early promise in advanced solid tumors

An off-the-shelf T-cell receptor therapy has shown promising early results in multiple solid tumor types, according to initial data from a phase 1 dose-escalation trial presented at ESMO Congress.

News
March 22, 2022
2 min read
Save

Abemaciclib plus letrozole effective in treating recurrent ER-positive endometrial cancer

Abemaciclib plus letrozole effective in treating recurrent ER-positive endometrial cancer

Results from a phase 2 study showed that abemaciclib in combination with letrozole shrunk or stabilized tumors in 75% of patients with recurrent or persistent estrogen receptor-positive, or ER-positive, endometrial cancer.

View more